VICTR

April 19, 2018

VUMC drug repurposing initiative gaining momentum

Drug repurposing involves establishing an additional approved indication for a drug already at market.

Illustration of human intestinal tract
March 22, 2018

Grant bolsters study of potential new therapy for C. diff infection

According to the Centers for Disease Control and Prevention, in 2011 in the United States there were almost half a million Clostridium difficile infections, and one in 11 patients 65 or older with a healthcare-associated C. diff infection died within 30 days of diagnosis.

March 1, 2018

Study reveals safety signal from genes that mimic drugs

Prospective mothers taking a new class of cholesterol-lowering drugs might incur higher risk of spina bifida in their future children, according to a study published in the journal Drug Safety by researchers at Vanderbilt University Medical Center.

September 21, 2017

New lab formulary improves quality, cuts cost

An effort at Vanderbilt University Medical Center (VUMC) to enhance clinical decision making through cross-departmental collaboration and effective use of diagnostics has improved patient care and saved the institution more than $1 million in 2016, VUMC officials reported this week.

September 7, 2017

Community key to gender identity research effort

One of the key elements of the Vanderbilt Program for LGBTI Health, an innovative effort to improve health care for lesbian, gay, bisexual, transgender and intersex patients, is community engagement.

July 13, 2017

Lindsell named to key VICTR, IMPH and Biostatistics leadership roles

Christopher Lindsell, Ph.D., nationally known for building clinical, translational and emergency medicine research programs at the University of Cincinnati, has been named director of the Research Methods Program in the Vanderbilt Institute of Clinical and Translational Research (VICTR).